Liquidia Corporation (LQDA) Stock Analysis — Probabli.AI
AI-powered analysis for LQDA (Liquidia Corporation): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $61.86 · Market cap: $5.5B · AI outlook: Bullish
Liquidia Corporation (LQDA) represents a promising investment opportunity due to its exceptional revenue growth potential and strong market position. The company's recent announcements surrounding partnerships, clinical trial advancements, and strong analyst demand suggest favorable outlooks. Despite competitive pressures and regulatory challenges, Liquidia's innovative pipeline offers long-term…
Probabilistic 1-Year Outlook
- Bull 48% · Neutral 35% · Bear 17%
- 1-year price estimates — P10: $50 / P50: $71 / P90: $90
- Liquidia Corporation's strong analyst consensus and robust fundamentals, including high estimated revenue growth, indicate significant potential for positive price movement. The stock's recent positive headlines, strong…
5-Year Outlook
- Bull 55% · Neutral 30% · Bear 15%
- 5-year price estimates — P10: $46 / P50: $129 / P90: $199
SWOT Highlights
- Strength: Very high revenue growth estimates indicate exceptional growth trajectory.
- Strength: Analyst consensus as 'STRONG BUY' demonstrates market confidence.
- Risk: Regulatory scrutiny regarding patent dispute creates uncertainty.
- Risk: Competition from generic drugs may impact market share.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
7 Wall Street analysts rate LQDA a STRONG BUY with a mean price target of $64.83.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
LQDA forecast details · LQDA sentiment details
Recent saved forecast research
AI-generated research records, not evaluated investment results.
- Liquidia Corporation (LQDA) — saved
Liquidia Corporation (LQDA) represents a promising investment opportunity due to its exceptional revenue growth potential and strong market position. The company's recent announcements surrounding partnerships, clinical trial advancements,
- Liquidia Corporation (LQDA) — saved
Despite being subject to competitive and sector-specific hurdles, Liquidia Corporation (LQDA) demonstrates well-grounded bullish prospects due to its enhanced revenue guidance, product approval achievements, and expansion-oriented collabora
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.